{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T14:59:27Z","timestamp":1769525967329,"version":"3.49.0"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":74,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["79\/159\/2015\/NCD-III"],"award-info":[{"award-number":["79\/159\/2015\/NCD-III"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Cancer Grid","award":["2016\/001"],"award-info":[{"award-number":["2016\/001"]}]},{"DOI":"10.13039\/501100000732","name":"UK-India Education and Research Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000732","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tata Consultancy Services Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>During the 2-year maintenance treatment phase (MT) of acute lymphoblastic leukemia (ALL), personalized patient-specified titration of oral antimetabolite drug doses is required to ensure maximum tolerated systemic drug exposure. Drug titration is difficult to implement in practice and insufficient systemic drug exposure resulting from inadequate dose titration increases risk of ALL relapse.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Materials and Methods<\/jats:title>\n                  <jats:p>We developed an open-source R-based analytical toolkit, including the allMT R package and an interactive web-based R Shiny VIATAMIN application, to evaluate antimetabolite drug titration during MT.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Evaluation is initiated with basic visualization analysis of drug titration, in both individual patients and patient cohorts. Observations are supplemented with descriptive analyses of hematological toxicity frequency and prescriber compliance rates with protocol drug titration rules. In individual patients, visual and quantitative analyses indicate recurring potentially correctable suboptimal drug titration patterns. In patient cohorts, the toolkit enables evaluation of the impact of interventions to optimize MT drug titration.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>Incorporation of the toolkit in a forthcoming clinical decision support system for MT would enable real-time examination and course correction of drug titration practice.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Future versions will be enhanced to include other variables that influence drug titration practice, including clinical toxicity data and later, pharmacological markers of antimetabolite, adherence, and drug activity.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jamiaopen\/ooae089","type":"journal-article","created":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T08:30:39Z","timestamp":1726302639000},"source":"Crossref","is-referenced-by-count":2,"title":["Analysis toolkit for evaluation of drug titration practice in acute lymphoblastic leukemia maintenance"],"prefix":"10.1093","volume":"7","author":[{"given":"Tushar","family":"Mungle","sequence":"first","affiliation":[{"name":"School of Medical Sciences and Technology, Indian Institute of Technology Kharagpur , Kharagpur, West Bengal, 721 302, India"},{"name":"Tata Translational Cancer Research Centre, Tata Medical Center , Kolkata, West Bengal, 700 160, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ananya","family":"Mahadevan","sequence":"additional","affiliation":[{"name":"Tata Translational Cancer Research Centre, Tata Medical Center , Kolkata, West Bengal, 700 160, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayanta","family":"Mukhopadhyay","sequence":"additional","affiliation":[{"name":"Department of Computer Science and Engineering, Indian Institute of Technology Kharagpur , Kharagpur, West Bengal, 721 302, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangeeta Das","family":"Bhattacharya","sequence":"additional","affiliation":[{"name":"School of Medical Sciences and Technology, Indian Institute of Technology Kharagpur , Kharagpur, West Bengal, 721 302, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaskar","family":"Saha","sequence":"additional","affiliation":[{"name":"Tata Translational Cancer Research Centre, Tata Medical Center , Kolkata, West Bengal, 700 160, India"},{"name":"Department of Paediatric Haematology and Oncology, Tata Medical Center , Kolkata, West Bengal, 700 160, India"},{"name":"Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester , Manchester, M13 9PL, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shekhar","family":"Krishnan","sequence":"additional","affiliation":[{"name":"Tata Translational Cancer Research Centre, Tata Medical Center , Kolkata, West Bengal, 700 160, India"},{"name":"Department of Paediatric Haematology and Oncology, Tata Medical Center , Kolkata, West Bengal, 700 160, India"},{"name":"Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester , Manchester, M13 9PL, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,9,13]]},"reference":[{"key":"2024091323532777400_ooae089-B1","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","article-title":"Pediatric acute lymphoblastic leukemia","volume":"105","author":"Inaba","year":"2020","journal-title":"Haematologica"},{"key":"2024091323532777400_ooae089-B2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jamaoncol.2015.0245","article-title":"Systemic exposure to thiopurines and risk of relapse in children with acute lymphoblastic leukemia: a Children\u2019s Oncology Group study","volume":"1","author":"Bhatia","year":"2015","journal-title":"JAMA Oncol"},{"key":"2024091323532777400_ooae089-B3","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/s41375-022-01591-4","article-title":"Maintenance therapy for acute lymphoblastic leukemia: basic science and clinical translations","volume":"36","author":"Toksvang","year":"2022","journal-title":"Leukemia"},{"key":"2024091323532777400_ooae089-B4","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S1470-2045(17)30154-7","article-title":"DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial","volume":"18","author":"Nielsen","year":"2017","journal-title":"Lancet Oncol"},{"key":"2024091323532777400_ooae089-B5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s12098-023-04687-6","article-title":"Maintenance treatment in acute lymphoblastic leukemia: a clinical primer","volume":"91","author":"Krishnan","year":"2024","journal-title":"Indian J Pediatr"},{"key":"2024091323532777400_ooae089-B6","doi-asserted-by":"crossref","first-page":"2042098620958910","DOI":"10.1177\/2042098620958910","article-title":"The art and science of drug titration","volume":"11","author":"Caffrey","year":"2020","journal-title":"Ther Adv Drug Saf"},{"key":"2024091323532777400_ooae089-B7","author":"Mungle","year":"2023"},{"key":"2024091323532777400_ooae089-B8","author":"Mahadevan","year":"2023"},{"key":"2024091323532777400_ooae089-B9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13063-022-06033-1","article-title":"Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in India","volume":"23","author":"Das","year":"2022","journal-title":"Trials"},{"key":"2024091323532777400_ooae089-B10","doi-asserted-by":"publisher","author":"Mungle","year":"2023","DOI":"10.17632\/775HS9WRB5.1"},{"key":"2024091323532777400_ooae089-B11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/MPH.0000000000002796","article-title":"Hybrid email and outpatient clinics to optimize maintenance therapy in acute lymphoblastic leukemia","volume":"46","author":"Mungle","year":"2024","journal-title":"J Pediatr Hematol Oncol"},{"key":"2024091323532777400_ooae089-B12","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1365-2141.2005.05541.x","article-title":"LISA: a web-based decision-support system for trial management of childhood acute lymphoblastic leukaemia","volume":"129","author":"Bury","year":"2005","journal-title":"Br J Haematol"},{"key":"2024091323532777400_ooae089-B13","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.phoj.2021.04.025","article-title":"Developing an automated dose advice programme to assist adaptive antimetabolite dose decisions during maintenance therapy in acute lymphoblastic leukaemia","volume":"5","author":"Mungle","year":"2020","journal-title":"Pediatr Hematol Oncol J"}],"container-title":["JAMIA Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jamiaopen\/article-pdf\/7\/3\/ooae089\/59115553\/ooae089.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jamiaopen\/article-pdf\/7\/3\/ooae089\/59115553\/ooae089.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T08:30:54Z","timestamp":1726302654000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jamiaopen\/article\/doi\/10.1093\/jamiaopen\/ooae089\/7756738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jamiaopen\/ooae089","relation":{},"ISSN":["2574-2531"],"issn-type":[{"value":"2574-2531","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,7,1]]},"article-number":"ooae089"}}